Gabelli Funds’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-10,000
| Closed | -$56K | – | 1163 |
|
|
2019
Q1 | $56K | Sell |
10,000
-10,000
| -50% | -$56K | ﹤0.01% | 1105 |
|
|
2018
Q4 | $133K | Hold |
20,000
| – | – | ﹤0.01% | 1100 |
|
|
2018
Q3 | $213K | Buy |
20,000
+1,000
| +5% | +$10.7K | ﹤0.01% | 1094 |
|
|
2018
Q2 | $228K | Buy |
19,000
+1,400
| +8% | +$16.8K | ﹤0.01% | 1078 |
|
|
2018
Q1 | $151K | Hold |
17,600
| – | – | ﹤0.01% | 1099 |
|
|
2017
Q4 | $174K | Hold |
17,600
| – | – | ﹤0.01% | 1083 |
|
|
2017
Q3 | $216K | Hold |
17,600
| – | – | ﹤0.01% | 1072 |
|
|
2017
Q2 | $290K | Hold |
17,600
| – | – | ﹤0.01% | 1067 |
|
|
2017
Q1 | $252K | Hold |
17,600
| – | – | ﹤0.01% | 1075 |
|
|
2016
Q4 | $243K | Hold |
17,600
| – | – | ﹤0.01% | 1083 |
|
|
2016
Q3 | $318K | Sell |
17,600
-1,500
| -8% | -$27.1K | ﹤0.01% | 1072 |
|
|
2016
Q2 | $274K | Hold |
19,100
| – | – | ﹤0.01% | 1099 |
|
|
2016
Q1 | $228K | Hold |
19,100
| – | – | ﹤0.01% | 1083 |
|
|
2015
Q4 | $254K | Buy |
19,100
+4,815
| +34% | +$64K | ﹤0.01% | 1070 |
|
|
2015
Q3 | $153K | Hold |
14,285
| – | – | ﹤0.01% | 1053 |
|
|
2015
Q2 | $115K | Sell |
14,285
-1
| -0% | -$8 | ﹤0.01% | 1070 |
|
|
2015
Q1 | $94K | Sell |
14,286
-35,857
| -72% | -$236K | ﹤0.01% | 1064 |
|
|
2014
Q4 | $319K | Sell |
50,143
-14,428
| -22% | -$91.8K | ﹤0.01% | 1023 |
|
|
2014
Q3 | $637K | Hold |
64,571
| – | – | ﹤0.01% | 952 |
|
|
2014
Q2 | $728K | Hold |
64,571
| – | – | ﹤0.01% | 925 |
|
|
2014
Q1 | $782K | Sell |
64,571
-196,429
| -75% | -$2.38M | ﹤0.01% | 897 |
|
|
2013
Q4 | $3.29M | Buy |
261,000
+47,883
| +22% | +$603K | 0.02% | 659 |
|
|
2013
Q3 | $3.55M | Sell |
213,117
-6,282
| -3% | -$105K | 0.02% | 634 |
|
|
2013
Q2 | $3.33M | Buy |
+219,399
| New | +$3.33M | 0.02% | 614 |
|